About Us

Mahesh co-founded MedGenome and has focussed on strategy, organization building and strategic initiatives. Mahesh is passionate about building innovative companies that leverage science and technology, while also creating social impact. He co-founded GenomeAsia100K, a non-profit initiative for improving Asian representation in genomic research. Mahesh is the Founder and MD of Emerge Ventures that specializes in incubating product companies in the education, healthcare, and data/analytics sectors. He holds a B.Tech. degree in Electronics and Communications from IIT Madras and an MBA from IIM Calcutta. Mahesh is one of the youngest to be recognized as IIM Calcutta Distinguished Alumnus.

Sekar Seshagiri is a world leader in the field of genomics and drug discovery. Prior to his current role, he spent over 20 years at Genentech where he was a Staff Scientist and Associate Director. During his tenure at Genentech, he established a state-of-the-art genomics laboratory where he conducted research in cancer and cell signaling areas to support drug discovery and development. His research work has been at the forefront of understanding underlying genetic changes in cancer genomes through systematic identification of somatic mutations in large number of cancer types and subtypes using next generation sequencing, computational methods, and functional assays. He has authored and co-authored over 100 articles in peer-reviewed journals including Nature, Nature Genetics, Science, and Cancer Cell. He obtained his B.Sc., (Agriculture) and M.Sc., (Biotechnology) from Tamil Nadu Agricultural University, India, a M.S, (Software Engineering) from Golden Gate University, San Francisco, US and a Ph.D. in Genetics from the University of Georgia, Athens, GA, US.

Dr. Sakthivel joined MedGenome in 2013 and has been with the company since its inception. He played an integral part in setting up the lab processes and over the years served in various positions managing lab operations. He has been overseeing key service projects and is responsible for new test development, optimization, and validation. He oversees quality compliance and was instrumental in obtaining CAP accreditation for MedGenome. Dr. Sakthivel comes with a vast experience of 20 years in the field of genetics and molecular diagnostics with specific focus on NGS technology. Dr. Sakthivel has a PhD. in Human Genetics from BITS, Pilani.

Dr. Avi joined MedGenome in July 2020 and heads Sales for the company’s Actia, Claria and Micra divisions & Trident Diagnostics. He is responsible for sales strategy and operations. He comes with a strong scientific background and has a vast experience in leading and mentoring large teams. Prior to joining MedGenome, he led sales for SRL Diagnostics and was instrumental in launching & establishing India’s highest selling Hematology Analyzers from Erba, as SBU Head, India at Transasia Bio-Medicals Ltd. His experience ranges across different areas of Clinical laboratory practice & diagnostics business; Hematology, Clinical Biochemistry, Cytology, Clinical Research & Genomics.
Dr. Avi is a qualified medical council registered, MD Pathologist from Pad. Dr. D.Y.Patil Medical College, Mumbai with a Ph.D in Clinical Research from Texila American University and an MBA in HR & Hospital Administration from IICT, Lucknow.

Praveen joined MedGenome in 2018 as Associate Director-Marketing & Companion Diagnostics and currently serves as the Director for Oncology Sales & Companion Diagnostics. He is responsible for sales strategy and business development of MedGenome’s Prima division. His active involvement in product customization and his customer centric approach have been instrumental in building a strong network of relationships with key accounts. Praveen brings to MedGenome more than 25 years of experience in Pharma and Diagnostic service industry. He has worked with notable diagnostics brands such as SRL, Oncostem and OncQuest prior to MedGenome. Praveen holds an MBA with dual specialization in marketing and operations and a Diploma in Pharmacy and Pharmaceutical Sciences.

Paul joined MedGenome in 2014 and is one of the earliest team members to come aboard. He has been instrumental in setting up the IT infrastructure and building the Laboratory Information Management Systems (LIMS) for the company. He is responsible for the design and development of all software solutions, Operations Management Systems, Scientific Interpretation tools and IT & security initiatives of the organization. Prior to joining MedGenome, he worked with California Software where he successfully executed ERP projects across several companies Paul is an accomplished Software expert with over three decades of experience in various industries including Shipping & bunkering, Commodity trading, Risk management, and Life sciences.

Dr. Ravi Gupta is currently Vice President - Bioinformatics at MedGenome and leads the bioinformatics group that serves diagnostics, research, and drug discovery. Dr. Ravi completed his PhD in computer science from IIT Roorkee and did his postdoc in computational biology from Wistar Institute, Philadelphia under the mentorship of Prof. Ramana Davuluri. Dr. Ravi is a leading expert in computational biology, genomics, next generation sequencing and its application. He has authored and co-authored over fifty articles in peer-reviewed journals including Nature and Cell and presented works at many international conferences. His group is involved in developing solutions for genetic diagnostics, infectious diseases, and personalized medicine.

Hiranjith has over 15 years of experience in defining and executing commercial strategies within multi-national organizations. In his prior experience, he has led engagements with Janssen Biotech (formerly Centocor biotech), GE and Medimmune, among others, with the niche pharma consulting firm, ZS Associates. He has extensive experience with strategic planning for launch brands and in-market brands as part of franchise planning teams at Novartis. He is currently responsible for driving sales, marketing, and partnership activities for MedGenome in the US. He transitioned to focus on the US business after a successful stint as the Director for Corporate Planning, Marketing and Communications with MedGenome in India. His healthcare experience in brand planning, primary and secondary market research, analytics, forecasting, and competitive intelligence is leveraged in designing the commercial campaigns for the markets that MedGenome focuses on. Hiranjith holds a Master’s in Business Administration and an engineering degree. He has also completed certification courses in Machine Learning by Stanford University.

Dr. Vedam Ramprasad is a scientist with several peer-reviewed publications to his credit. He believes in harnessing the power of genomics for providing better outlook to patients. He has been with MedGenome since its inception and spearheads operations and strategy. He has been a prime driver in building the diverse genetic testing portfolio MedGenome offers. He is also credited for launching some of the critical genetic tests at an affordable price which include the Non-Invasive Prenatal test (NIPT), Carrier Screening test, and Liquid Biopsy to name a few. His commitment to adhere to the highest quality standards and processes has been instrumental in obtaining CAP accreditation for MedGenome. With over two decades of experience, Dr. Ramprasad was previously associated with Vision Research Foundation, Sankara Nethralaya, Spinco Biotech, and SciGenom labs. He holds a Master’s degree and a PhD from BITS, Pilani.

Surajit Chakrabartty is a financial expert with over 18 years of experience across diverse sectors such as e-Commerce, Retail, Media & Advertising, and Manufacturing. Process implementation and building financial enterprises are his core strengths. In his career span, Surajit has successfully managed multiple projects including ERP implementations and internal control systems design across organisations. At MedGenome, he leads the finance function and is responsible for treasury management, financial forecasting, planning, and budgeting, reporting and assessing future business risks. He has successfully automated multiple processes while adhering to quality standards, rules, and regulations. Surajit brings with him extensive experience and in-depth expertise of debt and other financing developed over his stellar career. Previously, he was associated with Redbus.in, Medybiz Pharma Private Limited, and Rediffusion Y&R. He is also featured as one of India’s Most Influential CFOs (awarded by the Chartered Institute of Management Accountants). Surajit is also a Chartered Accountant from ICAI.

Dr. Felix Olale is an entrepreneur and physician scientist, renowned for his work in building businesses and investing in healthcare in emerging markets. Prior to his current role, he served as the Chairman of the MedGenome Board and was Partner and the Global Co-Leader for Health Investments at LeapFrog Investments. He also serves as a Board Trustee and Chairman of the Governance Committee for PATH, a leading global health innovator and is a Member of EMPEA’s Africa Council. Dr. Olale has previously been the Chairman of the Excelsior Group and Senior Advisor to the International Finance Corporation (IFC). He was also the Co-founder of Strathmore Business School’s Institute for Healthcare Management, and a founding member of Safaricom’s Health Advisory Board. Dr. Olale holds a Bachelor of Arts (Hons.) in Molecular Biology from the University of Pennsylvania and Medical Degree and Doctorate from New York University’s School of Medicine.